JP2025507448A5 - - Google Patents

Info

Publication number
JP2025507448A5
JP2025507448A5 JP2024569671A JP2024569671A JP2025507448A5 JP 2025507448 A5 JP2025507448 A5 JP 2025507448A5 JP 2024569671 A JP2024569671 A JP 2024569671A JP 2024569671 A JP2024569671 A JP 2024569671A JP 2025507448 A5 JP2025507448 A5 JP 2025507448A5
Authority
JP
Japan
Application number
JP2024569671A
Other languages
Japanese (ja)
Other versions
JP2025507448A (ja
JPWO2023156409A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/053681 external-priority patent/WO2023156409A1/en
Publication of JP2025507448A publication Critical patent/JP2025507448A/ja
Publication of JP2025507448A5 publication Critical patent/JP2025507448A5/ja
Publication of JPWO2023156409A5 publication Critical patent/JPWO2023156409A5/ja
Pending legal-status Critical Current

Links

JP2024569671A 2022-02-15 2023-02-14 Vwf標的化単特異性抗体により血液障害を処置する方法 Pending JP2025507448A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263268040P 2022-02-15 2022-02-15
US63/268,040 2022-02-15
US202263269000P 2022-03-08 2022-03-08
US63/269,000 2022-03-08
PCT/EP2023/053681 WO2023156409A1 (en) 2022-02-15 2023-02-14 Methods of treating blood disorders with vwf-targeted monospecific antibodies

Publications (3)

Publication Number Publication Date
JP2025507448A JP2025507448A (ja) 2025-03-18
JP2025507448A5 true JP2025507448A5 (https=) 2026-02-20
JPWO2023156409A5 JPWO2023156409A5 (https=) 2026-02-20

Family

ID=85278579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024569671A Pending JP2025507448A (ja) 2022-02-15 2023-02-14 Vwf標的化単特異性抗体により血液障害を処置する方法

Country Status (8)

Country Link
US (1) US20250154283A1 (https=)
EP (1) EP4479435A1 (https=)
JP (1) JP2025507448A (https=)
KR (1) KR20240159860A (https=)
CN (1) CN119032109A (https=)
AU (1) AU2023221511A1 (https=)
CA (1) CA3244108A1 (https=)
WO (1) WO2023156409A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR133583A1 (es) * 2023-08-16 2025-10-15 Hemab Aps Métodos para tratar trastornos de la sangre con anticuerpos monoespecíficos dirigidos a vwf
WO2025174998A1 (en) * 2024-02-13 2025-08-21 Invetx, Inc. Anti-il-31ra antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201707139D0 (en) * 2017-05-04 2017-06-21 Imp Innovations Ltd Polypeptides

Similar Documents

Publication Publication Date Title
JP2025507448A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13153U (https=)
BY13150U (https=)
BY13158U (https=)
BY13145U (https=)
BY13144U (https=)
BY13143U (https=)
BY13142U (https=)
BY13141U (https=)
CN307046964S (https=)
BY13140U (https=)
CN307046554S (https=)
CN307045597S (https=)
BY13137U (https=)
BY13135U (https=)
CN307047591S (https=)